Clinical Oncology Next Generation Sequencing Market

The Clinical Oncology Next Generation Sequencing (NGS) market utilizes high-throughput genomic technology to analyze tumor DNA and RNA, enabling precision oncology. Key customers include hospitals, clinics, and laboratories that use the technology to identify cancer-driving mutations and guide treatment. Market growth is primarily driven by the rising prevalence of cancer, the strong adoption of precision medicine, increasing investment in genomics, and technological advancements in sequencing and AI-based data analysis.